Dossier · FBL · Dormant
FBL
Last analysed · · source: watchlist_research
Current thesis
META AI/superintelligence narrative flipped from accelerating to "show-me-the-margin" after the 2026-04-29 capex raise to $125-145B; META -22% from Aug-2025 ATH, below its 200-DMA, chopping. FBL (1.5x daily-reset ETF) bleeds in this tape — no momentum leg to buy here.
Invalidation trigger
META weekly close below $573 (Apr-2026 swing low) → continuation toward the $520 52-wk low; exit any FBL long. On a 1.5x daily-reset vehicle also hard-stop a probe on a META daily close under [entry redacted] No momentum entry until META reclaims 200-DMA (~[entry redacted]) on a weekly close.
Thesis status
Open commitment scored if the trigger above fires How this is scored →Current Thesis
FBL is not a company — it is the GraniteShares 1.5x Long META Daily ETF, a swap-based, daily-reset leveraged vehicle that delivers 150% of Meta Platforms' (META) daily move. So this dossier is really a META call expressed through a decaying instrument. As of 2026-06-04 META trades ~$617.61 (prior close $622.98 on 06-03), down ~22% from its 2026-08-12 ATH close of $788.15 and sitting below its 200-DMA (~$633–665). The AI/superintelligence narrative that drove the stock to $788 has flipped from "accelerating AI ROI" to a "show-me-the-margin" capex overhang: at the 2026-04-29 Q1 print Meta beat on revenue but raised 2026 capex guidance to $125–145B (from [entry redacted]–135B) and the stock fell >6% after hours. That is the opposite of a momentum setup. There is no accelerating leg to buy here, and a 1.5x daily-reset product bleeds in exactly the kind of sideways/down chop META is in. Stance: avoid fresh longs; LOW-conviction probe only on a confirmed 200-DMA reclaim.
Bull Case
- Fundamentals are not the problem. Q1 2026 (reported 2026-04-29): revenue $56.31B, +33% YoY, beat consensus $55.52B; operating margin held at 41% despite costs +35% YoY — genuine operating leverage.
- Ad engine still compounding. Q1 ad impressions +19% YoY and price-per-ad +12% YoY; the AI value-optimization suite is now a >$20B annual run-rate, more than doubled YoY — the AI capex is already monetizing inside the core ad stack.
- Cheap for a Mag7. P/E ~22.65 at a $1.58T cap (2026-06-04) — near the market multiple, a rare discount for hyperscale AI exposure. If Q2 (guide $58–61B, incl. ~2% FX tailwind) shows stable margins, sell-side $750–850 year-end targets re-engage.
- Narrative optionality intact. New Llama model debuted 2026-04-08; Meta Superintelligence Labs (post ~$14B Scale AI / Alexandr Wang deal) shipping "significantly upgraded" Meta AI. A superintelligence re-acceleration could re-rate the multiple — but it is not the current tape.
Bear Case
- Price structure is broken. META below the 200-DMA (~$633–665) and ~22% off ATH = downtrend/consolidation, not the strength this playbook buys. Cheap multiple + rolled-over structure = textbook value trap, not momentum.
- Capex is now the swing factor, and it cuts down. The market sold the 2026-04-29 raise to $125–145B (-6% AH). Q1 capex alone was $19.8B. Any further upward revision = more margin overhang.
- Leverage decay is a structural tax. FBL resets daily via swaps; in choppy/sideways tape (META's regime since April) the 1.5x compounding erodes value even if META nets flat. The instrument punishes the "wait for it to come back" trap automatically.
- Q1 EPS quality flag. GAAP EPS $10.44 flattered by an $8.03B tax benefit; ex-benefit EPS was $7.31 — the headline overstated the beat.
Setup & Price Structure
- Spot: META ~$617.61 (2026-06-04), in the $612–622 resistance shelf. 52-wk range $520.26–$796.25.
- 200-DMA ~$633–665: price is below it → bearish/neutral structure. Reclaiming this zone on a weekly close is the line that turns the tape.
- Support: $573 (April-2026 swing low), then $520.26 (52-wk low). Resistance: $612–622 (here) → $660–673 → $750 → $788 ATH.
- FBL read-through: with META below its 200-DMA and chopping in a ~$45 box, FBL is in its worst possible regime — no trend to amplify, daily decay grinding. A probe is only justified after META trends, not in the range.
Catalyst Calendar (next 30 days)
- 2026-06-15 — META dividend ex-date, $0.525. Mechanical ~0.08% gap on META; negligible for FBL (price-tracking). Not a tradeable catalyst.
- No narrative catalyst inside 30 days. The next binary is Q2 2026 earnings, est. ~2026-07-29 (Q1 printed 2026-04-29) — outside the window; capex/margin commentary there is the real fork. DEFER/SKIP any position within 3 trading days of it.
- Watch (undated): further Meta Superintelligence Labs / Llama model releases and any leaked capex revisions — these have moved the tape 5%+ intraday in 2026.
What Would Change Our Mind
- Bull flip → LOW probe: META reclaims the 200-DMA (~[entry redacted]) on a weekly close with the broader Mag7/AI-software cohort breaking out together (cluster confirmation). Then FBL becomes a legitimate momentum vehicle.
- Bull flip → MEDIUM: above + Q2 (est. 2026-07-29) shows stable/expanding margins without another capex raise — removes the overhang that's capping the stock.
- Stay-out / SKIP confirmed: META holds below [entry redacted] and loses $573 on a weekly close → continuation toward $520; FBL is un-ownable in that decay.
- Hard avoid: any further 2026 capex guide-up above $145B with no offsetting margin commitment.
Correlation Notes
- FBL ≈ 1.5x META, full stop. Single-name concentration; treat any FBL size as 1.5x the equivalent META notional for risk. No diversification benefit vs a META position — do not hold both.
- Cohort: moves with Mag7 AI-software platforms (GOOGL, MSFT, AMZN) and the broader "AI capex ROI" debate — when the market punishes hyperscaler capex, META leads down. Inversely correlated to risk-off / rate-up regimes given the long-duration AI bet.
- Theme state: ai-mag7-software-platforms is MATURING→SATURATED on META specifically — capex skepticism is now the consensus frame (CNBC/Fortune headlines on the $145B raise = late-stage narrative). Not the 3-6-weeks-early entry this playbook hunts.
Operator Bottom Line
Strength is the setup in this book, and FBL has none right now: below 200-DMA, capex-narrative cooling, choppy tape that decays the leverage. This is a watch-and-wait, not a buy. Re-arm only on a weekly 200-DMA reclaim with cohort confirmation.